Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market
Information and Holders of Common Stock
Our
common stock is listed on the NYSE American, under the symbol “NRXS”.
As
of March 12, 2026, there were approximately 1,585 record holders of our common stock. The number of record holders does not include beneficial
owners of common stock whose shares are held in the names of banks, brokers, nominees or other fiduciaries and holders of unissued shares
of common stock.
The
last reported sales price for our Common Stock as reported on the NYSE American on March 12, 2026 was $6.48.
Dividends
We
have not declared or paid any cash dividends on our common stock, and we do not anticipate declaring or paying cash dividends for the
foreseeable future. We are not subject to any legal restrictions respecting the payment of dividends, except that we may not pay dividends
if the payment would render us insolvent. Any future determination as to the payment of cash dividends on our common stock will be at
the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements and other
factors that the board of directors considers to be relevant.
Recent
Sales of Unregistered Securities
On
October 29, 2025, 3,334 restricted stock units (“RSUs”) vested into an equivalent number of shares of common
stock.
On
January 22, 2026, the Company granted 437,431 RSUs pursuant to the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan as amended
on August 15, 2024. The RSUs vest annually pro rata over a three-year period and are payable in shares of the Company’s common
stock. The RSUs fully vest upon (i) death or disability or (ii) change of control. Dividend equivalents accrue on RSUs and are paid upon
vesting; there were no accrued dividends on unvested RSUs as of the report date.
Also
on January 22, 2026, the Company issued 86,392 shares of common stock to its independent board members for their 2025 and 2026
service.
ITEM
6. RESERVED
64
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.